Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Sales | 33,601 | 45,631 | 0 | 0 | 0 |
| Cost of Goods | 16,933 | 16,254 | 0 | N/A | N/A |
| Gross Profit | 16,668 | 29,377 | 0 | N/A | N/A |
| Operating Expenses | 78,701 | 81,123 | 0 | 0 | 0 |
| Operating Income | -61,100 | -51,492 | N/A | N/A | N/A |
| Other Income | -237 | -222 | 0 | 0 | 0 |
| Pre-tax Income | -61,337 | -51,714 | 0 | 0 | 0 |
| Income Tax | -2,020 | -599 | 0 | N/A | N/A |
| Net Income Continuous | -59,317 | -51,115 | N/A | N/A | N/A |
| Net Income | $-59,317 | $-51,115 | $0 | $N/A | $N/A |
| EPS Basic Total Ops | -2.93 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -2.93 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -2.93 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -2.93 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-58,193 | $-49,471 | $666 | $N/A | $N/A |